📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Benzimidazole compound abrogates SARS-COV-2 receptor-binding domain (RBD)/ACE2 interaction In vitro. (2023)

First Author: Omotuyi O

Attributed to: Non-Communicable Diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.micpath.2023.105994

PubMed Identifier: 36682669

Publication URI: http://europepmc.org/abstract/MED/36682669

Type: Journal Article/Review

Volume: 176

Parent Publication: Microbial pathogenesis

ISSN: 0882-4010